Indirect Hyperbilirubinemia. Neonatal jaundice due to excessive hemolysis, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group are treated by phototherapy and capsules of Urosobil (manufactured by Alborz Pharmaceuticals and dissolved in 10 cc infant milk) at 10 mg/kg
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Days to 14 Days
Inclusion criteria
Inclusion criteria: Birth weight more than 2500 gr Gestational age more than 37 weeks The birthday more than 2 days and less than two weeks The total bilirubin level is 14-20 mg/dl and the direct bilirubin level is less than 2 mg/dl No Septicemia lack of Crigler–Najjar syndrome lack of Thyroid disease lack of Liver disease lack of direct hyperbilirubinemai Incompatibility of blood groups and RH lack of G6PD deficiency Infants aged 2 to 14 days
Exclusion criteria
Exclusion criteria: Parental dissatisfaction for any reason The incidence of any side effects of Ursodeoxycholic acid Infants from diabetic mother
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total bilirubin. Timepoint: The time intervals for measuring total bilirubin levels are at the baseline (before the intervention), 12, 24, and 36 hours after starting treatment (phototherapy with or without Ursobil). Method of measurement: Autoanalyzer devices. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: During the intervention at 12, 24, and 36 hours after intervention. Method of measurement: Clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMitrah Aldaghi
Sabzevar University of Medical Sciences
Outcome results
None listed